GENETEC | GENETEC TECHNOLOGY BERHAD
0.300 (-1.64%)
T-O (am): 0.305 (08:59:00)
Last updated: 12:14
GENETEC Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
GENETEC Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 Nov 25 | Q1 Sep 25 | 1 | 30 Jun 26 | 34.34 | -42.30 | -42.30 | -123.2% | 0.00 | -5.46 | 23.4% | 14.6% | 7.5% | 987.2% | ||||||||
| 28 Aug 25 | Q4 Jun 25 | 4 | 30 Jun 25 | 44.80 | -41.69 | -45.71 | -102.0% | 0.00 | -5.84 | 40.4% | 13.0% | 6122.7% | 550.0% | ||||||||
| 29 May 25 | Q3 Mar 25 | 3 | 30 Jun 25 | 75.12 | 3.15 | 0.76 | 1.0% | 0.00 | 0.10 | 20.1% | 6.6% | 88.4% | 95.5% | ||||||||
| 27 Feb 25 | Q2 Dec 24 | 2 | 30 Jun 25 | 62.56 | 6.79 | 6.54 | 10.4% | 0.00 | 0.84 | 55.6% | 18.7% | 37.1% | 71.9% | ||||||||
| 26 Nov 24 | Q1 Sep 24 | 1 | 30 Jun 25 | 40.20 | 4.43 | 4.77 | 11.9% | 0.00 | 0.61 | 21.9% | 44.5% | 53.1% | 74.2% | ||||||||
| 29 Aug 24 | 30 Jun 24 | Other | 30 Jun 24 | 51.49 | 7.63 | 10.16 | 19.7% | 2.00 | 1.32 | 26.9% | 32.0% | 39.7% | 41.5% | ||||||||
| 28 May 24 | 31 Mar 24 | Other | 30 Jun 24 | 70.47 | 19.06 | 16.84 | 23.9% | 0.00 | 2.21 | 8.4% | 10.1% | 27.7% | 1.5% | ||||||||
| 27 Feb 24 | 31 Dec 23 | Other | 30 Jun 24 | 76.91 | 25.16 | 23.29 | 30.3% | 0.00 | 3.07 | 6.2% | 9.7% | 26.2% | 82.5% | ||||||||
| 28 Nov 23 | 30 Sep 23 | Other | 30 Jun 24 | 72.44 | 18.75 | 18.45 | 25.5% | 0.00 | 2.45 | 4.3% | 2.5% | 6.2% | 26.4% | ||||||||
| 29 Aug 23 | Q1 Jun 23 | 1 | 31 Mar 24 | 75.70 | 19.79 | 17.38 | 23.0% | 0.00 | 2.32 | 3.4% | 3.4% | 1.7% | 6.0% | ||||||||
| 31 May 23 | Q4 Mar 23 | 4 | 31 Mar 23 | 78.39 | 19.03 | 17.09 | 21.8% | 0.00 | 2.48 | 7.9% | 33.5% | 34.0% | 25.4% | ||||||||
| 27 Feb 23 | Q3 Dec 22 | 3 | 31 Mar 23 | 85.14 | 13.88 | 12.76 | 15.0% | 0.00 | 1.87 | 20.5% | 30.5% | 49.1% | 30.2% | ||||||||
| 28 Nov 22 | Q2 Sep 22 | 2 | 31 Mar 23 | 70.66 | 27.94 | 25.05 | 35.5% | 0.00 | 3.67 | 3.5% | 19.1% | 35.5% | 53.6% | ||||||||
| 29 Aug 22 | Q1 Jun 22 | 1 | 31 Mar 23 | 73.21 | 19.44 | 18.49 | 25.3% | 0.00 | 2.71 | 24.7% | 81.8% | 35.7% | 126.0% | ||||||||
| 26 May 22 | Q4 Mar 22 | 4 | 31 Mar 22 | 58.70 | 14.84 | 13.63 | 23.2% | 0.00 | 2.00 | 10.1% | 349.3% | 25.5% | 339.7% | ||||||||
| 26 Jan 22 | Q3 Dec 21 | 3 | 31 Mar 22 | 65.26 | 21.01 | 18.28 | 28.0% | 0.00 | 35.83 | 10.0% | 98.3% | 12.1% | 1956.5% | ||||||||
| 25 Oct 21 | Q2 Sep 21 | 2 | 31 Mar 22 | 59.31 | 17.59 | 16.31 | 27.5% | 0.00 | 32.25 | 47.3% | 53.4% | 99.3% | 518.3% | ||||||||
| 29 Jul 21 | Q1 Jun 21 | 1 | 31 Mar 22 | 40.28 | 8.86 | 8.18 | 20.3% | 0.00 | 16.28 | 208.3% | 224.1% | 243.9% | 491.7% | ||||||||
| 25 May 21 | Q4 Mar 21 | 4 | 31 Mar 21 | 13.07 | -6.56 | -5.68 | -43.5% | 0.00 | -13.03 | 60.3% | 57.0% | 739.5% | 27.3% | ||||||||
| 09 Feb 21 | Q3 Dec 20 | 3 | 31 Mar 21 | 32.91 | 0.84 | 0.89 | 2.7% | 0.00 | 2.06 | 14.9% | 17.9% | 66.3% | 89.5% | ||||||||
| 25 Nov 20 | Q2 Sep 20 | 2 | 31 Mar 21 | 38.67 | 2.69 | 2.64 | 6.8% | 0.00 | 6.18 | 211.2% | 167.0% | 226.3% | 1489.2% | ||||||||
| 27 Aug 20 | Q1 Jun 20 | 1 | 31 Mar 21 | 12.43 | -1.79 | -2.09 | -16.8% | 0.00 | -4.93 | 49.4% | 28.7% | 73.3% | 118.5% | ||||||||
| 24 Jun 20 | Q4 Mar 20 | 4 | 31 Mar 20 | 8.32 | -8.74 | -7.82 | -94.0% | 0.00 | -18.50 | 79.2% | 42.0% | 192.6% | 109.6% | ||||||||
| 26 Feb 20 | Q3 Dec 19 | 3 | 31 Mar 20 | 40.11 | 8.12 | 8.45 | 21.1% | 0.00 | 19.97 | 176.9% | 16.2% | 4987.9% | 69.2% | ||||||||
| 25 Nov 19 | Q2 Sep 19 | 2 | 31 Mar 20 | 14.48 | -0.19 | 0.17 | 1.1% | 0.00 | 0.39 | 16.9% | 25.7% | 117.4% | 75.5% | ||||||||
| 28 Aug 19 | Q1 Jun 19 | 1 | 31 Mar 20 | 17.42 | -0.51 | -0.96 | -5.5% | 0.00 | -2.26 | 21.4% | 39.5% | 74.4% | 126.0% | ||||||||
| 28 May 19 | Q4 Mar 19 | 4 | 31 Mar 19 | 14.36 | -5.56 | -3.73 | -26.0% | 0.00 | -9.19 | 58.4% | 50.6% | 174.8% | 2247.2% | ||||||||
| 26 Feb 19 | Q3 Dec 18 | 3 | 31 Mar 19 | 34.52 | 5.06 | 4.99 | 14.5% | 2.50 | 12.42 | 77.1% | 25.7% | 636.1% | 83.3% | ||||||||
| 28 Nov 18 | Q2 Sep 18 | 2 | 31 Mar 19 | 19.50 | 0.84 | 0.68 | 3.5% | 0.00 | 1.71 | 32.3% | 0.1% | 81.6% | 170.0% | ||||||||
| 21 Aug 18 | Q1 Jun 18 | 1 | 31 Mar 19 | 28.79 | 3.89 | 3.68 | 12.8% | 2.50 | 9.32 | 0.9% | 14.9% | 2412.6% | 89.0% | ||||||||
| 22 May 18 | Q4 Mar 18 | 4 | 31 Mar 18 | 29.05 | 0.19 | -0.16 | -0.6% | 0.00 | -0.44 | 5.8% | 58.8% | 105.8% | 91.9% | ||||||||
| 28 Feb 18 | Q3 Dec 17 | 3 | 31 Mar 18 | 27.47 | 3.66 | 2.72 | 9.9% | 0.00 | 7.67 | 41.1% | 91.3% | 381.3% | 221.9% | ||||||||
| 21 Nov 17 | Q2 Sep 17 | 2 | 31 Mar 18 | 19.47 | -0.53 | -0.97 | -5.0% | 0.00 | -2.72 | 22.3% | 21.3% | 149.8% | 64.3% | ||||||||
| 29 Aug 17 | Q1 Jun 17 | 1 | 31 Mar 18 | 25.05 | 2.58 | 1.95 | 7.8% | 0.00 | 5.53 | 37.0% | 14.2% | 199.2% | 110.3% | ||||||||
| 24 May 17 | Q4 Mar 17 | 4 | 31 Mar 17 | 18.29 | -2.01 | -1.96 | -10.7% | 0.00 | -5.57 | 27.4% | 10.3% | 12.3% | 60.8% | ||||||||
| 24 Feb 17 | Q3 Dec 16 | 3 | 31 Mar 17 | 14.36 | -1.87 | -2.23 | -15.6% | 0.00 | -6.35 | 10.6% | 27.5% | 279.3% | 9.7% | ||||||||
| 22 Nov 16 | Q2 Sep 16 | 2 | 31 Mar 17 | 16.05 | -0.52 | -0.59 | -3.7% | 0.00 | -1.67 | 26.8% | 58.6% | 163.7% | 118.7% | ||||||||
| 24 Aug 16 | Q1 Jun 16 | 1 | 31 Mar 17 | 21.93 | 0.81 | 0.93 | 4.2% | 0.00 | 2.63 | 32.2% | 59.3% | 175.9% | 79.5% | ||||||||
| 24 May 16 | Q4 Mar 16 | 4 | 31 Mar 16 | 16.59 | -0.09 | -1.22 | -7.3% | 0.00 | -3.47 | 16.2% | 65.8% | 40.2% | 164.3% | ||||||||
| 24 Feb 16 | Q3 Dec 15 | 3 | 31 Mar 16 | 19.80 | -1.33 | -2.04 | -10.3% | 0.00 | -0.58 | 48.9% | 49.6% | 164.5% | 230.5% | ||||||||
| 18 Nov 15 | Q2 Sep 15 | 2 | 31 Mar 16 | 38.78 | 3.71 | 3.16 | 8.1% | 0.00 | 0.90 | 28.0% | 41.2% | 29.9% | 447.0% | ||||||||
| 19 Aug 15 | Q1 Jun 15 | 1 | 31 Mar 16 | 53.84 | 5.97 | 4.50 | 8.4% | 0.00 | 1.28 | 11.1% | 75.6% | 137.6% | 967.1% | ||||||||
| 29 May 15 | Q4 Mar 15 | 4 | 31 Mar 15 | 48.46 | 0.69 | 1.90 | 3.9% | 0.00 | 0.54 | 23.3% | 158.1% | 21.4% | 38.8% | ||||||||
| 13 Feb 15 | 31/12/14 | 3 | 31/03/15 | 39.30 | 1.70 | 1.56 | 4.0% | 0.00 | 0.44 | 43.1% | 63.6% | 170.5% | 619.4% |
GENETEC Historical Dividends
GENETEC Financial Ratios
| EPS | -10.2 sen |
| Trailing PE (Sector Median: 29.6) | 0.0 |
| PEG | 0.0 |
| Altman Z | 0.8 |
| Beaver | -0.32 |
| Current Ratio | 2.92 |
| Debt-Equity (DE) Ratio | 0.34 |
| FCF Yield | -19.96 % |
| Revenue QoQ | -23.35 % |
| Revenue YoY | -14.58% |
| Profit QoQ | 7.46 % |
| Profit YoY | -987.23 % |
| Profit Margin (Sector Median: 5.2) | -37.23 % |
| ROE (ROIC: -20.65) | -20.69 % |
| Dividend Per Share (DPS) | 0.0 sen |
| Dividend Yield (DY) | 0.0 % |
GENETEC Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 29.6) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 5.2) | |
| ROE (ROIC: -17.82) | |
| Altman Z |
GENETEC Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.5 | Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | -42.06 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0.0 |
| Expected Revenue (M) | 0.0 |
| Expected Growth (%) | 0.0 |
GENETEC Directors Share Purchases (Beta)
MR TEH KIM SENG reduced 300000.0 units announced on 27 Apr 2023 at ~RM2.78
MR TAN MOON TEIK reduced 1200000.0 units announced on 30 Jan 2023 at ~RM2.72
MADAM ONG PHOE BE reduced 30000.0 units announced on 27 Dec 2022 at ~RM2.68
MADAM ONG PHOE BE reduced 40000.0 units announced on 19 Dec 2022 at ~RM2.71
MR CHIN KEM WENG added 20000.0 units announced on 15 Nov 2021 at ~RM41.9
MADAM ONG PHOE BE reduced 500.0 units announced on 08 Sep 2021 at ~RM29.08
MADAM ONG PHOE BE reduced 5000.0 units announced on 01 Sep 2021 at ~RM29.4
MADAM ONG PHOE BE reduced 5000.0 units announced on 16 Aug 2021 at ~RM25.68
MR TEH KIM SENG reduced 100000.0 units announced on 24 Jun 2021 at ~RM5.67
MR TAN MOON TEIK added 40000.0 units announced on 25 Feb 2021 at ~RM5.51
MR TAN MOON TEIK added 38000.0 units announced on 24 Feb 2021 at ~RM5.66
MR TAN MOON TEIK added 183000.0 units announced on 22 Feb 2021 at ~RM5.55
MADAM ONG PHOE BE reduced 30000.0 units announced on 18 Feb 2021 at ~RM5.58
MR TAN MOON TEIK added 140000.0 units announced on 16 Feb 2021 at ~RM3.89
GENETEC Summary
Market Cap: 237 M.
Market Cap Class: Small caps
Number of Shares: 791 M.
Adjusted Float: 88.7%.
Stock highly correlated with
CEB (92%)
JIANKUN (91%)
PARKSON (91%)
CNASIA (90%)
Genetec Technology Berhad, incorporated in 1997 and headquartered in Bandar Baru Bangi, Malaysia, specializes in the design, development, and manufacturing of intelligent automation systems, serving as a key contract manufacturer for customized factory automation equipment and integrated vision inspection systems. Through its broad capabilities in assembly solutions, material handling, precision tooling, in-house machining, and prototyping, Genetec delivers end-to-end automation solutions across sectors such as electric vehicles and batteries, automotive, semiconductor, consumer electronics, computer peripherals, and healthcare. Its offerings range from conceptual equipment design and prototyping to mass equipment replication, supporting high-precision manufacturing environments. With a focus on innovation and scalability, Genetec operates across Malaysia and serves an international clientele spanning Asia, Europe, and North America.
Sectors: Technology, Trading & Services, Technology Equipment, Semiconductors, Automation, Electric Vehicles, Precision Machining, Penny Stocks
Code: 0104
Website: https://genetec.net
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
GENETEC Top Shareholdings
Updated on 10-Nov-2025
Frequently Asked Questions
GENETEC TECHNOLOGY BERHAD Latest News
GENETEC Insights+
Some features of iSaham Insights are exclusively available to iSaham Pro clients.
Learn More about iSaham ProResearch House Target Price
Average Target Price: N/A
Entitlements
(Bonus Issue, Share Split or Share consolidation for the past 3 years)
| Ex-Date | Category | Entitlements |
|---|---|---|
| No entitlements detected |
Private Placements
(Fund raising via private placement shares for the past 3 years)
| Date | Stage | Purpose | Issue Price |
|---|---|---|---|
| No Private Placements detected |